# To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study

> **NCT07660536** · PHASE2,PHASE3 · COMPLETED · sponsor: **Creighton University** · enrollment: 60 (actual)

## Conditions studied

- Osteoporosis (Senile)

## Interventions

- **DRUG:** doxercalciferol capsules, Hectorol®
- **DRUG:** Matched Placebo (Capsules)

## Key facts

- **NCT ID:** NCT07660536
- **Lead sponsor:** Creighton University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1989-11-14
- **Primary completion:** 1992-04-22
- **Final completion:** 1994-12-23
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660536, "To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07660536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*